Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-04-04 16:01:26
Reporting Period:
Filing Date:
Accepted Time:
2017-04-04 16:01:26
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1517022 Akebia Therapeutics Inc. AKBA Pharmaceutical Preparations (2834) 208756903
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591098 Duane Nash C/o Akebia Therapeutics, Inc.
245 First Street
Cambridge MA 02142
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-04-03 991 $9.20 24,677 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Shares sold by reporting person pursuant to a 10b5-1 plan to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award.
  2. The price reported is a weighted average price. This transaction was executed in multiple trades at prices ranging from $9.19 to $9.21, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.